ClinicalTrials.Veeva

Menu
Allied Biomedical Research Institute | Miami, FL logo

Allied Biomedical Research Institute | Miami, FL

Research site
About
Phase 1-4 Center. Neurology, Psychiatry, Rheumatology, Cardiology, Pain, Nephrology, GI and Hepatology.

Site insights

Top conditions

Top treatments

Cenerimod
ABBV-932
KarXT
RO7790121
Lanabecestat
BLI5100
ENT-01
LY3314814
Centanafadine
Gantenerumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Luis Estevez

Verified by this site

Active trials

25 of 65 total trials
Recently updated

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus (OPUS-1)

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to seve...

Active, not recruiting
Lupus Erythematosus, Systemic
Drug: Placebo
Drug: Cenerimod

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to sever...

Active, not recruiting
Lupus Erythematosus, Systemic
Drug: Cenerimod
Drug: Placebo

The goal of this clinical trial is to learn if cenerimod, on top of regular treatment, works to treat active lupus nephritis in adults with systemic...

Enrolling
Lupus Erythematosus, Systemic
Nephritis, Lupus
Drug: Placebo
Drug: Cenerimod

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participant...

Active, not recruiting
Chronic Migraine
Drug: Placebo
Drug: Galcanezumab

The purpose of this study is to evaluate the efficacy and safety of telitacicept in the treatment of generalized myasthenia gravis.

Enrolling
Generalized Myasthenia Gravis
Drug: Placebo
Biological: Telitacicept
Locations recently updated

This is a Phase 3, 38-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with psychosis associated with Al...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: Placebo
Drug: KarXT

This is a Phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and efficacy of KarXT in male and female...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: KarXT
Drug: Placebo

This Phase III, multicenter, double-blind, placebo-controlled, treat-through study will evaluate the efficacy and safety of Afimkibart (RO7790121) co...

Active, not recruiting
Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Drug: Placebo
Locations recently updated

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO779...

Enrolling
Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Drug: Placebo

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (also...

Enrolling
Moderately to Severely Active Crohns Disease
Drug: Placebo
Drug: Afimkibart

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the efficacy, safety, and tolerab...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: Placebo
Drug: ITI-1284

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Placebo

A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease.

Enrolling
Parkinson Disease
Drug: Placebo
Drug: BHV-8000

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopa...

Active, not recruiting
Idiopathic Gastroparesis
Drug: Placebo
Drug: CIN-102 Dose 15mg
Locations recently updated

The goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients with moderate to severe sympto...

Invitation-only
Lupus Erythematosus, Systemic
Drug: Cenerimod

This study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatmen...

Enrolling
Agitation
Alzheimer's Type Dementia
Drug: Masupirdine 100 mg
Drug: Placebo

This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN0...

Enrolling
Psychosis Associated With Alzheimer's Disease
Drug: KarXT

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Randomized efficacy and safety study of piromelatine 20 mg versus placebo in participants with mild dementia due to Alzheimer's disease (AD) who are...

Active, not recruiting
Alzheimer's Disease
Drug: Piromelatine 20 mg
Drug: Placebo

Trial sponsors

Roche logo
AbbVie logo
Otsuka logo
V
K
AstraZeneca logo
Braintree Laboratories logo
E
Intra-Cellular Therapies logo
LG Chem logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems